A Leader in Clinical Research
Clinical Trials at UMDNJ

FEATURES

Aging
Confronting Alzheimer’s • Decoding Dementias • Parkinson’s, Anxiety and Depression • Exercising the Aging Brain • Moving Forward • Nursing Research Fosters Independence

Pediatrics
Where Kids Volunteer • The Doctor’s Orders: A Cure • More Options for Kids’ Psychiatric Problems • Autism Therapies on Trial

Inflammation
Diagnosis: Scleroderma • Beyond the Standard of Care • The Old Exercise Remedy • For Her Patients’ Sake

Cancer
Staying Alive • New Trials to Beat Cancer • Recruiting Minorities for Cancer Trials • Adding Years With Experimental Therapies • Promising Medicines to Try • Trials for Gastrointestinal Malignancies

Dentistry
Smiling Once Again • The Puzzle of Burning Mouth Syndrome • Down in the Mouth

Women’s Health
Targeting Women’s Cancers • Putting Women First • Help for Headaches • Bringing Basic Science to the Clinic • Sleep and Fibromyalgia Symptoms

Cardiology
Protecting the Heart [and the Brain] • 911: Endangered Heart

Environment
On the Road Again • What’s in the Paint? • Treating Tobacco Dependency and Mental Illness • Kids and Their Environments: a Landmark Study • The Cancer/Clock Connection

Infection
Healthy Volunteers: The Inside Scoop • HIV Has A Female Face • Liver Disease: de la Torre's Dilemma • TB Trials: Secrets to Success

Community
Man with a Mission • Numbers Count  • Battling TB Here and Abroad • Breaking Down Barriers to Cancer Care • Her Happy Ending for HIV Pregnancy • Triggering Change in Transfusion Medicine

Endpage
Five Questions with Paula Bistak

Your comments and letters are welcome. Please send them to:

umdnjeditor@umdnj.edu

UMDNJ-University Marketing Communications
Unversity Heights
65 Bergen Street
P.O. Box 1709, Suite 1328
Newark, NJ 07101-1709

 

Women's Health
Sleep and Fibromyalgia Symptoms
words by mary ann littell

L
print this
Share this:

esley A. Allen, PhD, associate professor, psychiatry, UMDNJ-Robert Wood Johnson Medical School, is currently conducting an investigator-initiated clinical trial assessing the efficacy of Lunesta (eszopiclone) in the treatment of fibromyalgia symptoms, including sleep problems, pain and fatigue. Given that eszopiclone has been demonstrated to improve sleep in other populations, the researcher hypothesized that Lunesta would enhance the sleep of patients with fibromyalgia.

She recently completed another trial assessing the efficacy of a cognitive-behavioral intervention on the symptoms and functioning of patients with somatization disorder. A first trial assessing the efficacy of a similar intervention was published in 2006. This second study was conducted to determine the effect of a more intensive treatment, including group and individual therapy. Some 75 to 85 percent of Allen's study subjects are women.